Camille Granvil

A Phase I, Multicenter, Open-Label, First-in-Human, Dose-Escalation Study of the Oral Smoothened Inhibitor Sonidegib (LDE225) in Patients with Advanced Solid Tumors

Jordi Rodón, Hussein Tawbi, Anne Thomas et al. · Clinical Cancer Research · 2014 · 231 citations · Full text

Pharmacy, Oncology, Pharmacology +17

The CYP2D6 Humanized Mouse: Effect of the Human CYP2D6 Transgene and HNF4 on the Disposition of Debrisoquine in the Mouse

Javier Corchero, Camille Granvil, Taro E. Akiyama et al. · Molecular Pharmacology · 2001 · 139 citations

Medicine, Pharmacology, Toxicology +16

Plasma exposure of imatinib and its correlation with clinical response in the Tyrosine Kinase Inhibitor Optimization and Selectivity Trial

François Guilhot, Timothy P. Hughes, Jörge E. Cortes et al. · Haematologica · 2012 · 130 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +15

Expression of the Human CYP3A4 Gene in the Small Intestine of Transgenic Mice: In Vitro Metabolism and Pharmacokinetics of Midazolam

Camille Granvil, Ai‐Ming Yu, Guillermo Elizondo et al. · Drug Metabolism and Disposition · 2003 · 105 citations

Medicine, Pharmacokinetics, Pharmacology +17

Role of CYP2B6 and CYP3A4 in the In Vitro N-Dechloroethylation of (R)- and (S)-Ifosfamide in Human Liver Microsomes

Camille Granvil, Ajay Madan, Mahmoud Sharkawi et al. · Drug Metabolism and Disposition · 1999 · 90 citations

Medicine, Biochemistry, Pharmacology +13